Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®

Clinical trial NCT00319553 · COMPLETED

Trial details

NCT number: NCT00319553
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pertussis Tetanus Diphtheria

Start date: 2006-05-01
Primary completion: 2008-10-01
Enrollment: 647

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.